Focused on the future of Market Access
Where consulting meets agency
As a fully integrated, multi-specialty group, we enhance decision-making and communication between payers and pharmaceutical manufacturers
product launches
supported last year
out of the 24
US cell & gene therapies supported
value-based contracts
implemented
Simplifying access and reimbursement
Delivering expert strategy and success through our market access consulting, communications, and engagement approach
Decision-maker difference
Full-time former payers provide real-world insights and strategic expertise that surpass industry norms
Kim Gwiazdzinski
Senior Vice President, Value & Access
Previously Prime Therapeutics & Cigna
Jim Clement
Senior Vice President, Value & Access
Previously Aetna & ESI
Doug Brown
Senior Vice President, Value & Access
Previously Magellan Rx
Harry Vargo
Senior Vice President, Value & Access
Formerly Aetna & CVS
Matt Paul
Senior Vice President, Value & Access
Formerly Skyward Specialty Insurance
COEBRA® Outcomes & Evidence Platform
The world's leading value-based health and innovative contract management solution.